Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hyman

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Journal of Psychiatric Research|June 3, 2011
The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placeboMark Hyman Rapaport, Andrew A Nierenberg, Robert Howland, et al.
The American Journal of Psychiatry|March 1, 2002
Amnesia and neonaticideMauro V Mendlowicz, Mark Hyman Rapaport, Leonardo Fontenelle, et al.
The International Journal of Neuropsychopharmacology|July 23, 2005
The effects of celecoxib augmentation on cytokine levels in schizophreniaCatherine J Bresee, Katia Delrahim, Rachel E Maddux, et al.
Biological Psychiatry|June 15, 2005
Celecoxib augmentation of continuously ill patients with schizophreniaMark Hyman Rapaport, Katia K Delrahim, Catherine J Bresee, et al.
Journal of Affective Disorders|August 29, 2003
Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patientsJeffrey M Pyne, William J Sieber, Kristin David, et al.
Complementary Therapies in Medicine|November 16, 2020
Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findingsMark Hyman Rapaport, Pamela J Schettler, Erika R Larson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2012
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient settingWaguih William Ishak, Konstantin Balayan, Catherine Bresee, et al.
IRB|November 3, 2011
Researcher experiences with IRBs: a survey of members of the American College of NeuropsychopharmacologyKatherine L Wisner, Robert R Conley, Stephan F Taylor, et al.
Current Psychiatry Reports|November 14, 2009
The role of dopaminergic agents in improving quality of life in major depressive disorderWaguih William IsHak, Michael Davis, Jessica Jeffrey, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Journal of Psychiatric Research|June 3, 2011
The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placeboMark Hyman Rapaport, Andrew A Nierenberg, Robert Howland, et al.
The American Journal of Psychiatry|March 1, 2002
Amnesia and neonaticideMauro V Mendlowicz, Mark Hyman Rapaport, Leonardo Fontenelle, et al.
The International Journal of Neuropsychopharmacology|July 23, 2005
The effects of celecoxib augmentation on cytokine levels in schizophreniaCatherine J Bresee, Katia Delrahim, Rachel E Maddux, et al.
Biological Psychiatry|June 15, 2005
Celecoxib augmentation of continuously ill patients with schizophreniaMark Hyman Rapaport, Katia K Delrahim, Catherine J Bresee, et al.
Journal of Affective Disorders|August 29, 2003
Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patientsJeffrey M Pyne, William J Sieber, Kristin David, et al.
Complementary Therapies in Medicine|November 16, 2020
Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findingsMark Hyman Rapaport, Pamela J Schettler, Erika R Larson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2012
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient settingWaguih William Ishak, Konstantin Balayan, Catherine Bresee, et al.
IRB|November 3, 2011
Researcher experiences with IRBs: a survey of members of the American College of NeuropsychopharmacologyKatherine L Wisner, Robert R Conley, Stephan F Taylor, et al.
Current Psychiatry Reports|November 14, 2009
The role of dopaminergic agents in improving quality of life in major depressive disorderWaguih William IsHak, Michael Davis, Jessica Jeffrey, et al.
Pageof 8